What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Genetics, Retinitis pigmentosa, Gene, Mutation and Molecular biology.
As part of his studies on Genetics, he often connects relevant areas like Rhodopsin.
He has researched Rhodopsin in several fields, including Congenital stationary night blindness, Mutant and Transversion.
His Retinitis pigmentosa research integrates issues from Retinal degeneration, Missense mutation, Electroretinography and Visual phototransduction.
His Molecular biology research includes elements of Retina and Exon.
Thaddeus P. Dryja has included themes like Chromosome 13, Cancer research, Germline mutation and Somatic cell in his Retinoblastoma study.
His most cited work include:
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma (2374 citations)
- Expression of recessive alleles by chromosomal mechanisms in retinoblastoma (1642 citations)
- A point mutation of the rhodopsin gene in one form of retinitis pigmentosa (865 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Genetics, Retinitis pigmentosa, Gene, Molecular biology and Mutation.
His study involves Allele, Locus, Missense mutation, Exon and Retinoblastoma, a branch of Genetics.
The study incorporates disciplines such as Chromosome 13, Cancer research, DNA and Retinoblastoma gene in addition to Retinoblastoma.
His Retinitis pigmentosa study integrates concerns from other disciplines, such as Retinal degeneration, Rhodopsin and Electroretinography.
His Rhodopsin research is multidisciplinary, relying on both Retina and Mutant.
Molecular biology is frequently linked to Gene mutation in his study.
He most often published in these fields:
- Genetics (46.34%)
- Retinitis pigmentosa (28.66%)
- Gene (27.13%)
What were the highlights of his more recent work (between 2009-2021)?
- Pathology (13.11%)
- Ophthalmology (15.55%)
- Gene (27.13%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Pathology, Ophthalmology, Gene, Retina and Pharmacology.
His studies deal with areas such as Hyaluronic acid, Dermal Fillers, PAX8 and Eyelid as well as Pathology.
His work carried out in the field of Ophthalmology brings together such families of science as Animal model, Psychiatry and Age related.
His Gene study contributes to a more complete understanding of Genetics.
Thaddeus P. Dryja interconnects Complement system, Viral vector, Nucleic acid and Cancer research in the investigation of issues within Retina.
He combines subjects such as Antibody, Neutralizing antibody and Bioinformatics with his study of Pharmacology.
Between 2009 and 2021, his most popular works were:
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis (771 citations)
- Supplementary Materials for Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis (156 citations)
- Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa (104 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Gene, Genetics, Internal medicine, Antibody and Psoriasis.
His Gene research is multidisciplinary, incorporating perspectives in Retina, Nucleic acid and Virology.
His work is connected to Retinitis pigmentosa, Linkage disequilibrium, Haplotype, Single-nucleotide polymorphism and Minor allele frequency, as a part of Genetics.
His work deals with themes such as Sensorineural hearing loss and Mutation, Frameshift mutation, Exon, which intersect with Retinitis pigmentosa.
His Antibody research includes themes of Receptor, Retinal, Pharmacology and Peptide.
His Psoriasis research is multidisciplinary, incorporating elements of Rheumatoid arthritis, Uveitis and Rheumatology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
